{"title":"Survival of Patients on Maintenance Hemodialysis Base on Comorbidity of Cardiovascular Disease in Persahabatan Central General Hospital 2015-2019","authors":"Mila Fitriaty, N. Adnan, M. Syafiq","doi":"10.31965/infokes.vol19.iss2.547","DOIUrl":null,"url":null,"abstract":"Chronic kidney disease is the progressive loss of kidney function over months or years. The significant increase in new cases of chronic kidney disease is in line with the increasing number of patients undergoing hemodialysis as kidney replacement therapy in an effort to survive. Comorbid cardiovascular disease is a major risk factor for morbidity and mortality with chronic kidney disease. The study was conducted to determine the survival of hemodialysis patients in the group with comorbid cardiovascular disease and the group without comorbid cardiovascular disease. This study used a retrospective cohort design. The location of this study was conducted at Persahabatan Central Public Hospital, DKI Jakarta, and used secondary data from the hospital information system data from 2015 to 2019. The variables significantly related to the survival of patients undergoing hemodialysis with comorbid cardiovascular disease were age, complications of anemia, diabetes mellitus, and hypertension. The age variable has a p-value of 0.029 with an HR of 1.54 (95% CI OR 1.043-2.262). The anemia variable has a p-value of 0.013 with an HR of 1.60 (95% CI 1.117-2.515). The diabetes mellitus variable has a p-value of 0.000 with HR2.71 (95% CI 1.780-4.11). The hypertension variable has a p-value of 0.004 with HR1.79 (95% CI 1.208-2.646). In conclusion, patients undergoing hemodialysis with comorbid cardiovascular disease have a risk of death of 0.76 times compared to patients undergoing hemodialysis with the comorbid non-cardiovascular disease. This study's internal validity was not good due to selection bias and non-differential misclassification information bias. Thus, the results of this study cannot be generalized.","PeriodicalId":34064,"journal":{"name":"Jurnal Info Kesehatan","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Info Kesehatan","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31965/infokes.vol19.iss2.547","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Chronic kidney disease is the progressive loss of kidney function over months or years. The significant increase in new cases of chronic kidney disease is in line with the increasing number of patients undergoing hemodialysis as kidney replacement therapy in an effort to survive. Comorbid cardiovascular disease is a major risk factor for morbidity and mortality with chronic kidney disease. The study was conducted to determine the survival of hemodialysis patients in the group with comorbid cardiovascular disease and the group without comorbid cardiovascular disease. This study used a retrospective cohort design. The location of this study was conducted at Persahabatan Central Public Hospital, DKI Jakarta, and used secondary data from the hospital information system data from 2015 to 2019. The variables significantly related to the survival of patients undergoing hemodialysis with comorbid cardiovascular disease were age, complications of anemia, diabetes mellitus, and hypertension. The age variable has a p-value of 0.029 with an HR of 1.54 (95% CI OR 1.043-2.262). The anemia variable has a p-value of 0.013 with an HR of 1.60 (95% CI 1.117-2.515). The diabetes mellitus variable has a p-value of 0.000 with HR2.71 (95% CI 1.780-4.11). The hypertension variable has a p-value of 0.004 with HR1.79 (95% CI 1.208-2.646). In conclusion, patients undergoing hemodialysis with comorbid cardiovascular disease have a risk of death of 0.76 times compared to patients undergoing hemodialysis with the comorbid non-cardiovascular disease. This study's internal validity was not good due to selection bias and non-differential misclassification information bias. Thus, the results of this study cannot be generalized.
慢性肾脏疾病是指几个月或几年肾脏功能的逐渐丧失。慢性肾脏疾病新病例的显著增加与接受血液透析作为肾脏替代疗法以生存的患者数量的增加是一致的。并发心血管疾病是慢性肾脏疾病发病率和死亡率的主要危险因素。本研究旨在确定合并心血管疾病组和未合并心血管疾病组血液透析患者的生存。本研究采用回顾性队列设计。本研究的地点在雅加达DKI Persahabatan中央公立医院进行,并使用了2015年至2019年医院信息系统数据中的二次数据。年龄、贫血并发症、糖尿病和高血压与合并心血管疾病的血液透析患者的生存率有显著关系。年龄变量的p值为0.029,HR为1.54 (95% CI OR 1.043-2.262)。贫血变量的p值为0.013,HR为1.60 (95% CI 1.117-2.515)。糖尿病变量的p值为0.000,HR2.71 (95% CI 1.780-4.11)。高血压变量的p值为0.004,HR1.79 (95% CI 1.208-2.646)。综上所述,合并心血管疾病的血液透析患者的死亡风险是合并非心血管疾病的血液透析患者的0.76倍。由于选择偏倚和非差异误分类信息偏倚,本研究的内部效度不佳。因此,本研究的结果不能一概而论。